{"id":152658,"date":"2026-08-30T19:21:41","date_gmt":"2026-08-30T17:21:41","guid":{"rendered":"https:\/\/dev.surfbox.de\/?p=152658"},"modified":"2026-08-30T19:21:41","modified_gmt":"2026-08-30T17:21:41","slug":"ucinak-regorafeniba-u-lijecenju-tumora","status":"publish","type":"post","link":"https:\/\/dev.surfbox.de\/es\/ucinak-regorafeniba-u-lijecenju-tumora\/","title":{"rendered":"U\u010dinak Regorafeniba u Lije\u010denju Tumora"},"content":{"rendered":"

Regorafenib je ciljano terapijsko sredstvo koje je odobreno za lije\u010denje razli\u010ditih tipova tumora, uklju\u010duju\u0107i metastatski kolorektalni karcinom, hepatski karcinom i gastrointestinalne stromalne tumore. Ovaj lijek djeluje tako da blokira odre\u0111ene proteine koji su klju\u010dni za rast stanica tumora i njihovu sposobnost \u0161irenja, \u010dime se smanjuje napredovanje bolesti.<\/p>\n

Za detaljnije informacije o u\u010dinku Regorafeniba u lije\u010denju, mo\u017eete posjetiti ovu poveznicu<\/a>.<\/p>\n

Mehanizam djelovanja Regorafeniba<\/h2>\n

Regorafenib djeluje kroz nekoliko mehanizama:<\/p>\n

    \n
  1. Inhibicija receptora:<\/strong> Ovaj lijek blokira angiogenezu, proces potrebnog za formiranje novih krvnih \u017eila koje opskrbljuju tumor.<\/li>\n
  2. Antitumorski u\u010dinak:<\/strong> Regorafenib smanjuje rast stanica tumora tako \u0161to cilja va\u017ene signalne puteve unutar stanica.<\/li>\n
  3. Imunolo\u0161ki odgovor:<\/strong> Mo\u017ee pomo\u0107i u ja\u010danju imunolo\u0161kog odgovora tijela protiv tumora.<\/li>\n<\/ol>\n

    Indikacije i doziranje<\/h2>\n

    Regorafenib se obi\u010dno propisuje pacijentima koji su ve\u0107 isprobali druge terapije bez zna\u010dajnog uspjeha. Standardna doza za odrasle obi\u010dno iznosi 160 mg dnevno, dovoljno dugo da se postigne optimalan u\u010dinak, uz prilago\u0111avanje prema potrebama pacijenta.<\/p>\n

    Potencijalne nuspojave<\/h2>\n

    Kao i kod svake druge terapije, primjena Regorafeniba mo\u017ee izazvati nuspojave. Me\u0111u naj\u010de\u0161\u0107im su:<\/p>\n

      \n
    1. Umor<\/li>\n
    2. Proljev<\/li>\n
    3. Bolovi u trbuhu<\/li>\n
    4. Poreme\u0107aji u funkciji jetre<\/li>\n<\/ol>\n

      Zaklju\u010dak<\/h2>\n

      Regorafenib predstavlja va\u017enu opciju u lije\u010denju razli\u010ditih tumora, osobito kod pacijenata kod kojih su druge terapije neuspje\u0161ne. Va\u017eno je da se svako lije\u010denje provodi pod pa\u017enjom stru\u010dnjaka i uz redovito pra\u0107enje stanja pacijenta.<\/p>\n","protected":false},"excerpt":{"rendered":"

      Regorafenib je ciljano terapijsko sredstvo koje je odobreno za lije\u010denje razli\u010ditih tipova tumora, uklju\u010duju\u0107i metastatski kolorektalni karcinom, hepatski karcinom i gastrointestinalne stromalne tumore. Ovaj lijek djeluje tako da blokira odre\u0111ene proteine koji su klju\u010dni za rast stanica tumora i njihovu sposobnost \u0161irenja, \u010dime se smanjuje napredovanje bolesti. Za detaljnije informacije o u\u010dinku Regorafeniba u lije\u010denju,…<\/p>\n","protected":false},"author":214,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[155],"tags":[],"yoast_head":"\nU\u010dinak Regorafeniba u Lije\u010denju Tumora - ba\u00fal de techo hecha de GRP por Mobila<\/title>\n<meta name=\"description\" content=\"Regorafenib je ciljano terapijsko sredstvo koje je odobreno za lije\u010denje razli\u010ditih tipova tumora, uklju\u010duju\u0107i metastatski kolorektalni karcinom, hepatski\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U\u010dinak Regorafeniba u Lije\u010denju Tumora - ba\u00fal de techo hecha de GRP por Mobila\" \/>\n<meta property=\"og:description\" content=\"Regorafenib je ciljano terapijsko sredstvo koje je odobreno za lije\u010denje razli\u010ditih tipova tumora, uklju\u010duju\u0107i metastatski kolorektalni karcinom, hepatski\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/\" \/>\n<meta property=\"og:site_name\" content=\"ba\u00fal de techo hecha de GRP por Mobila\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-30T17:21:41+00:00\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"support\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dev.surfbox.de\/#website\",\"url\":\"https:\/\/dev.surfbox.de\/\",\"name\":\"ba\\u00fal de techo hecha de GRP por Mobila\",\"description\":\"Mobila GmbH produces premium roof boxes skiboxes & Surf boxes\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dev.surfbox.de\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/#webpage\",\"url\":\"https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/\",\"name\":\"U\\u010dinak Regorafeniba u Lije\\u010denju Tumora - ba\\u00fal de techo hecha de GRP por Mobila\",\"isPartOf\":{\"@id\":\"https:\/\/dev.surfbox.de\/#website\"},\"datePublished\":\"2026-08-30T17:21:41+00:00\",\"dateModified\":\"2026-08-30T17:21:41+00:00\",\"author\":{\"@id\":\"https:\/\/dev.surfbox.de\/#\/schema\/person\/d2069f1478da8b3b8c1edcb3d7d031b7\"},\"description\":\"Regorafenib je ciljano terapijsko sredstvo koje je odobreno za lije\\u010denje razli\\u010ditih tipova tumora, uklju\\u010duju\\u0107i metastatski kolorektalni karcinom, hepatski\",\"breadcrumb\":{\"@id\":\"https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dev.surfbox.de\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U\\u010dinak Regorafeniba u Lije\\u010denju Tumora\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/dev.surfbox.de\/#\/schema\/person\/d2069f1478da8b3b8c1edcb3d7d031b7\",\"name\":\"support\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/dev.surfbox.de\/#personlogo\",\"inLanguage\":\"es\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0918a90067b2bc2cf7083f70de687098?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0918a90067b2bc2cf7083f70de687098?s=96&d=mm&r=g\",\"caption\":\"support\"},\"url\":\"https:\/\/dev.surfbox.de\/es\/author\/support\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"U\u010dinak Regorafeniba u Lije\u010denju Tumora - ba\u00fal de techo hecha de GRP por Mobila","description":"Regorafenib je ciljano terapijsko sredstvo koje je odobreno za lije\u010denje razli\u010ditih tipova tumora, uklju\u010duju\u0107i metastatski kolorektalni karcinom, hepatski","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"es_ES","og_type":"article","og_title":"U\u010dinak Regorafeniba u Lije\u010denju Tumora - ba\u00fal de techo hecha de GRP por Mobila","og_description":"Regorafenib je ciljano terapijsko sredstvo koje je odobreno za lije\u010denje razli\u010ditih tipova tumora, uklju\u010duju\u0107i metastatski kolorektalni karcinom, hepatski","og_url":"https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/","og_site_name":"ba\u00fal de techo hecha de GRP por Mobila","article_published_time":"2026-08-30T17:21:41+00:00","twitter_misc":{"Escrito por":"support","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/dev.surfbox.de\/#website","url":"https:\/\/dev.surfbox.de\/","name":"ba\u00fal de techo hecha de GRP por Mobila","description":"Mobila GmbH produces premium roof boxes skiboxes & Surf boxes","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.surfbox.de\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/#webpage","url":"https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/","name":"U\u010dinak Regorafeniba u Lije\u010denju Tumora - ba\u00fal de techo hecha de GRP por Mobila","isPartOf":{"@id":"https:\/\/dev.surfbox.de\/#website"},"datePublished":"2026-08-30T17:21:41+00:00","dateModified":"2026-08-30T17:21:41+00:00","author":{"@id":"https:\/\/dev.surfbox.de\/#\/schema\/person\/d2069f1478da8b3b8c1edcb3d7d031b7"},"description":"Regorafenib je ciljano terapijsko sredstvo koje je odobreno za lije\u010denje razli\u010ditih tipova tumora, uklju\u010duju\u0107i metastatski kolorektalni karcinom, hepatski","breadcrumb":{"@id":"https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.surfbox.de\/ucinak-regorafeniba-u-lijecenju-tumora\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.surfbox.de\/es\/"},{"@type":"ListItem","position":2,"name":"U\u010dinak Regorafeniba u Lije\u010denju Tumora"}]},{"@type":"Person","@id":"https:\/\/dev.surfbox.de\/#\/schema\/person\/d2069f1478da8b3b8c1edcb3d7d031b7","name":"support","image":{"@type":"ImageObject","@id":"https:\/\/dev.surfbox.de\/#personlogo","inLanguage":"es","url":"https:\/\/secure.gravatar.com\/avatar\/0918a90067b2bc2cf7083f70de687098?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0918a90067b2bc2cf7083f70de687098?s=96&d=mm&r=g","caption":"support"},"url":"https:\/\/dev.surfbox.de\/es\/author\/support\/"}]}},"_links":{"self":[{"href":"https:\/\/dev.surfbox.de\/es\/wp-json\/wp\/v2\/posts\/152658"}],"collection":[{"href":"https:\/\/dev.surfbox.de\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dev.surfbox.de\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dev.surfbox.de\/es\/wp-json\/wp\/v2\/users\/214"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.surfbox.de\/es\/wp-json\/wp\/v2\/comments?post=152658"}],"version-history":[{"count":1,"href":"https:\/\/dev.surfbox.de\/es\/wp-json\/wp\/v2\/posts\/152658\/revisions"}],"predecessor-version":[{"id":152659,"href":"https:\/\/dev.surfbox.de\/es\/wp-json\/wp\/v2\/posts\/152658\/revisions\/152659"}],"wp:attachment":[{"href":"https:\/\/dev.surfbox.de\/es\/wp-json\/wp\/v2\/media?parent=152658"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dev.surfbox.de\/es\/wp-json\/wp\/v2\/categories?post=152658"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dev.surfbox.de\/es\/wp-json\/wp\/v2\/tags?post=152658"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}